Detalles de la búsqueda
1.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
2.
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study.
Invest New Drugs
; 31(4): 1035-43, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23417697
3.
Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study.
Support Care Cancer
; 21(6): 1691-5, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23314653
4.
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients.
Front Oncol
; 13: 1125013, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895480
5.
Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study.
Support Care Cancer
; 20(6): 1221-6, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21688165
6.
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Support Care Cancer
; 19(8): 1159-64, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20552375
7.
Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience.
Anticancer Res
; 41(5): 2553-2561, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33952483
8.
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest.
Eur J Cancer
; 139: 81-89, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979645
9.
Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.
JAMA Oncol
; 4(4): 529-536, 2018 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29450468
10.
Adjuvant chemotherapy in esophageal cancer.
Rays
; 31(1): 31-5, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16999373
11.
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.
PLoS One
; 11(7): e0157751, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27442239
12.
Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?
Springerplus
; 2(1): 185, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23667824
13.
Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.
PLoS One
; 8(12): e80188, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24339871
Resultados
1 -
13
de 13
1
Próxima >
>>